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OssiﬁcationMaxillary hypoplasia occurs due to insufﬁcient maxillary intramembranous ossiﬁcation, leading to poor dental
occlusion, respiratory obstruction and cosmetic deformities. Conditional deletion of Jagged1 (Jag1) in cranial
neural crest (CNC) cells using Wnt1-cre; Jagged1f/f (Jag1CKO) led to maxillary hypoplasia characterized by
intrinsic differences in bone morphology and density using μCT evaluation. Jag1CKO maxillas revealed altered
collagen deposition, delayed ossiﬁcation, and reduced expression of early and late determinants of osteoblast de-
velopment during maxillary ossiﬁcation. In vitro bone cultures on Jag1CKO mouse embryonic maxillary mesen-
chymal (MEMM) cells demonstrated decreased mineralization that was also associated with diminished
induction of osteoblast determinants. BMP receptor expression was dysregulated in the Jag1CKO MEMM cells
suggesting that these cells were unable to respond to BMP-induced differentiation. JAG1-Fc rescued in vitromin-
eralization and osteoblast gene expression changes. These data suggest that JAG1 signaling in CNC-derived
MEMM cells is required for osteoblast development and differentiation during maxillary ossiﬁcation.
© 2014 The Authors. Published by Elsevier Inc.Open access under CC BY-NC-ND license .Introduction
Craniofacial bone development occurs through intramembranous
ossiﬁcation via direct osteoblast differentiation of neural crest derived
mesenchyme [1]. Maxillary hypoplasia arises when the upper jaw fails
to elongate, causing an outwardly-visible sunken appearance to the
mid-face which affects mastication, respiration, and communication.
Costly and invasive corrective surgery is the only clinical option to
treat this debilitating condition accounting for more than an estimated
76.5 million dollars in annual medical costs. Thus there is a signiﬁcant
need to characterize normal and pathologic maxillary developmentRS, Alizarin red staining; BMP,
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.Open access under CC BY-NC-ND licto provide a mechanism-based understanding necessary to identify
novel therapeutic targets to potentially prevent and/or treat maxillary
hypoplasia.
Although the cause of maxillary hypoplasia is likely multifactorial, it
can manifest from intrinsic growth deﬁciency seen in humans with
Alagille syndrome (JAG1 and NOTCH mutations) [2,3]. As such, our
overarching hypothesis is that the JAG1–NOTCH pathway is necessary
and essential for maxillary development. In support, we have previ-
ously reported a mouse model of post-natal maxillary hypoplasia in
Wnt1-cre+; Jagged1f/f conditional knockouts (Jag1CKOs) caused by in-
trinsic maxillary growth deﬁciencies that result in death by P21 due
to starvation from the inability to masticate [4]. The JAG1–NOTCH
signaling axis plays critical roles during bony development andmainte-
nance; however, there are conﬂicting reports on the inhibitory or induc-
tive potential of the NOTCH pathway during osteoblastogenesis [5–10].
JAG1 is a transmembrane bound ligand that binds NOTCH receptors
(NOTCH1–4) inducing cell fate, proliferation/apoptosis, and differentia-
tion [11]. Once ligand is bound, the NOTCH intracellular domain (NICD)
is cleaved by γ-secretase and translocated to the nucleus to associate
with transcription factors recombining binding protein suppressor of
hairless (RBPJ) and mastermind-like (MAML). This interaction directly
up-regulates the expression of transcription factors Hairy/Enhancer of
Split (HES) and HES-related genes (HEY, CHF, HRT, HESR) [12] which
modulate down-stream canonical Notch signaling. Hence, the purpose
of this work was to determine the role of canonical JAG1 signalingense.
11C.R. Hill et al. / Bone 62 (2014) 10–21during maxillary osteoblast development and identify critical down-
stream targets of this pathway that could explain our observed maxil-
lary hypoplasia phenotype.
Through complementary in vivo and in vitro experiments we reveal
that intrinsic differences during development and post-natal growth
of the Jag1CKO maxillary bone are associated with the inability of max-
illary mesenchymal cells to undergo osteoblast differentiation andmin-
eralization. The addition of JAG1-Fc restored Jag1CKOmesenchymal cell
responsiveness to osteogenic media in vitro, conﬁrming the necessity of
JAG1 for osteoblast development. These results are the ﬁrst to reveal a
uniquemodel ofmaxillary hypoplasia that allows the study of maxillary
intramembranous ossiﬁcation in the context of cell-autonomous JAG1




Jag1CKO mice were generated as previously described [4].Wnt1-cre
mice were obtained from Jax labs and Jag1f/f mice were a gift from Dr.
Kathleen Loomes [13–15]. Jag1f/f; Wnt1-cre− (control) and Jag1f/f;
Wnt1-cre+ (Jag1CKO) mice were analyzed at E14, E16, E18, and P14
via timedpregnancies. All procedures and protocolswere done in accor-
dance with a Vanderbilt IACUC approved protocol.
Micro-computed tomography
Control and Jag1CKO mice were sacriﬁced by CO2 inhalation at P14.
The skull was placed in 10% formalin for 24 h and bone properties
were determined using micro-computed tomography (μCT). Skulls
were loaded into standard μCT tubes (diameter 12.3 mm) and aligned
with the scanning axis of a μCT apparatus (Scanco μCT-40 Medical;
Switzerland). Subsequent to identifying the region of interest from a
scout scan data was acquired at a resolution of 12 μm voxels (isotropic)
with projections every 1° through 180° at unvarying X-ray source set-
tings (55 keV and 145 μA). Through algorithms provided by Scanco,
datawas determined as bone volume, bone fraction volume, bone tissue
mineral density, and anisotropy. Analysis was targeted at two different
anatomic areas of the skull, anterior and posterior portions of the
maxilla (Figs. 1A and B: green and red cylinders), in both control and
Jag1CKO mice.
Tissue preparation
Embryos were harvested at E14, E16, and E18, genotyped, and proc-
essed as previously described [4]. Brieﬂy, heads were ﬁxed in 4% para-
formaldehyde (PFA) for 30 min to 1 h and frozen in optimal cutting
temperature (OCT) media after sucrose dehydration. All staining were
performed on 8 μm thick coronal sections that were thawed and
rehydrated in phosphate buffered saline (PBS).
In vivo ossiﬁcation
Tri-chrome. Slides were ﬁxed in 4% PFA for 10 min followed by 2
washes in PBS for 5 min each and washed in running dH2O for 5
min. Slides were then incubated in Weigerts Hematoxylin for 5 min
followed by a 5min rinse in running dH2O. Sections were dehydrated
in 1% HCl/70% EtOH for 5 min and rinsed in running dH2O for 5 min
followed by several rinses in 95% EtOH. Without letting the slides
dry, workingMauritius yellow solution was applied for 2min follow-
ed by several changes in running dH2O. Slides were incubated in
working crystal ponceau 6R for 10 min, rinsed in dH2O, incubated
in 1% phosphotungstic acid for 5–10 min, and rinsed in dH2O. Methyl
blue solution was applied for 2–5 min followed by dH2O rinse. Slides
were ﬁnally dehydrated, cleared, and cover-slipped with clear mount-
ing media.Von Kossa. Slides were ﬁxed in 4% PFA for 10 min followed by 2 washes
in PBS for 5 min each and washed in running dH2O for 5 min. Slides
were incubated in a 5% silver nitrate solution in bright sunlight or
under 60-watt lamp for 1 h or until calcium turns black, and subse-
quently rinsed in 3 changes of dH2O. Next, 5% Hypo (sodium thiosul-
fate) solution is applied for 5 min and slides are rinsed in dH2O. Slides
were then incubated with nuclear fast red for 5 min and rinsed in
dH2O. Slides were ﬁnally dehydrated, cleared, and cover-slipped with
clear mounting media.
Quantiﬁcation of ossiﬁed areas. Image J software was used to calculate
the areas of ossiﬁcation both anteriorly and posteriorly in stained
sections from 3 embryos of control and Jag1CKO mice at E14, E16, and
E18.
Immunoﬂuorescence
After allowing slides to dry at room temperature for 15 min, slides
were ﬁxed in acetone (−80 °C) for 5 min and allowed to dry for
8 min. Slides were washed 3 times in PBS for 3–5 min each wash and
permeabilized in 3 successive changes of 0.1% Tween-20 for 3–5 min.
Sections were blocked with 10% donkey serum for 1 h at room temper-
ature and incubated with primary antibodies: CD-31 (BD Pharmingen)
and RUNX2 (Abcam) diluted in 1% donkey serum overnight at 4 °C.
The following day the slides are washed with PBS followed by 0.1%
Tween-20 as previously stated and incubated with secondary antibod-
ies (Invitrogen) for 1 h at room temperature. Finally they are washed
in PBS followed by dH2O and counterstained with hard mount DAPI
(Vectastain).
All imaging were performed on a Nikon E800 microscope, and im-
ages were obtained with SPOT imaging software (Diagnostic Instru-
ments, Inc.).
qPCR
To determine changes in gene expression, we used qPCR as previ-
ously described [16]. Total RNA was isolated using the TRIzol reagent
(Invitrogen) according to themanufacturer's protocol. cDNAwas gener-
ated from 1 μg total RNA using oligo-dT primers and Superscript III
polymerase (Invitrogen). Primer pairs are shown in Table 1. Real-time
PCR analysis was done with iQ SYBR green supermix (Bio-Rad) in the
Bio-Rad iCycler for 40 cycles. The expression levels are calculated
using the ΔΔCT method. The threshold cycle (CT) represents the PCR
cycle at which an increase of the reporter ﬂuorescence above the base-
line isﬁrst detected. The fold change in expression levels, R, is calculated
as follows: R = 2−ΔΔCT (where R = 2(ΔCT treated − ΔCT control)) to nor-
malize the abundance of all transcripts to the level of GAPDH RNA
expression.
Mouse embryonic maxillary mesenchymal cell culture
Primary mouse embryonic maxillary mesenchymal (MEMM) cells
were generated from E14 embryos. Embryos were harvested and the
maxilla was dissected and incubated in trypsin at 37 °C with 5% CO2
for 30 min. The epithelium was removed from the mesenchyme, and
the tissuewas pipetted up and down vigorously until the cells were dis-
persed. The cells were ﬁltered through a 100 μmmesh and cultured in
DMEM/F12 supplemented with 10% FBS and 100 μg/mL penicillin/
streptomycin.
Osteoblast mineralization
The capacity of MMEM cells to mineralize surrounding matrix
was tested by providing a conﬂuent monolayer osteogenic media
(OM): α-MEM containing 2.5% FBS, 100 μg/mL penicillin/streptomycin,
100 μg/mL ascorbic acid, 5 mM β-glycerophosphate, and 100 ng/mL
BMP2 (R&D Systems). To assure that osteogenic media were essential
for matrix mineralization, control wells were incubated in growth
media (GM): α-MEM containing 2.5% FBS, 100 μg/mL penicillin/
streptomycin, and vehicle. Cultures were incubated for 16 days at 37 °C
Fig. 1. Jagged1 is required for maxillary development. μCT was used to visualize the post-natal maxilla in control (A) and Jag1CKO (B) P14mice. Jag1 CKOmice had a signiﬁcantly shorter
maxillawhen compared to controlmicewith nodifference in the length of themandible. Compositional and structural properties of Jag1CKO'smaxillary (green cylinder) and palatine (red
cylinder) bones were measured and compared to controls (C–J). n = 3; *** = p b 0.05.
12 C.R. Hill et al. / Bone 62 (2014) 10–21with 5% CO2 with changes of media every 2 days. Cell cultures were
washed with PBS twice and ﬁxed in 4% PFA for 30min at room temper-
ature. The monolayers grown in each well of a 12 well tissue culture
plate were washed twice with dH2O prior to the addition of 500 μL of
40 mM alizarin red staining (ARS) solution and incubated for 20 min
at room temperature with gentle rocking. The monolayers were then
washed 4 times with excess dH2O for 4 min at room temperature
while shaking. The plateswere then tilted and left at an angle to remove
all excess water from the well. Plates were photographed and stored at
−20 °C until solubilization of the dye. To quantify ARS, 400 μL of 10%
acetic acid was added to each well and incubated for 30 min at room
temperature with shaking. The monolayers were transferred to a
1.5 mL microfuge tube by scraping each well with a cell scraper. The
tubes were vortexed for 30 min and 250 μL of mineral oil was added
to each tube. Each tube was heated to 85 °C for 10 min, cooled on icefor 5 min, and centrifuged at 20,000 g for 15 min. 250 μL of the acetic
acid phase was transferred to a new tube and 100 μL of 10% ammonium
hydroxide was added to neutralize the acid. Aliquots of each sample
were read on SpectraMax M5 (Molecular Devices) plate reader in trip-
licate at 405 nm in 96-well format using opaque-walled, transparent-
bottomed plates. Data was collected with Soft Max Pro (Molecular
Devices) software.
Cell proliferation
Cell proliferation following mineralization was measured using Cell
Proliferation Elisa, BrdU Colorimetric kit (Roche) according to the
manufacturer's protocol. Wells were read on SpectraMax M5 (Molecu-
lar Devices) plate reader in triplicate at 370 nm in 96-well format
using tissue culture treated ﬂat-bottomed plates. Data was collected
with Soft Max Pro (Molecular Devices) software. Total DNA extraction
Table 1
qPCR primer sequences.






















13C.R. Hill et al. / Bone 62 (2014) 10–21was used as an additional means of determining differences in cell pro-
liferation. Brieﬂy, cells were incubated in DNA lysis buffer overnight at
50 °C. DNA was precipitated with isopropanol and resuspended in Tris
buffer. DNA concentration was determined using Nanovue (GE©).
Immobilized JAG1-Fc
The process of ligand immobilization was performed as previously
described [17]. Brieﬂy, tissue culture plates were incubated with a solu-
tion of goat anti-human IgG antibody (20 μg/mL) in PBS for 30 min at
37 °C and subsequently blockedwith growthmedium for 30min. Plates
were then incubated with either IgG (10 μg/mL) or JAG1-Fc (10 μg/mL)
diluted in growth media for 2 h at 37 °C. Plates were washed with
growth media and cells were seeded.
JAG1 inhibition
DAPT (Sigma)was added to the culturemedium2 h before the addi-
tion of OM to yield a ﬁnal concentration of 50 μM. Concentration of the
gamma secretase inhibitor DAPT is comparable to that used in previous
studies [18,19]. Control wells, lacking inhibitor, were supplemented
with an equivalent volume of DMSO (Sigma). The inhibitor was added
with each media change and therefore present for the duration of the
experiment.
Statistical analysis
Paired Student's t-test was performed to establish signiﬁcance.
Data are presented as the mean of three experiments ± SEM for one
littermate pair, unless otherwise speciﬁed. p-Values of b0.05 were con-
sidered signiﬁcant.
Results
Maxillary hypoplasia in Jag1CKOmice is associated with reduced bone vol-
ume, bone mineral density, and bone organization
Three dimensional reconstruction of μCT data obtained from control
(Fig. 1A) and Jag1CKO (Fig. 1B) skulls illustrates severe maxillary hypo-
plasia in the Jag1CKOmice. In addition to the reduced size of themaxilla,
these images also reveal decreased ossiﬁcation of the maxillary and
palatine bones (Figs. 1A, B bottom images). Compositional algorithms
of these data reveal signiﬁcantly reduced mineralization of developing
bone as measured by bone volume, bone fraction volume (bone
volume/total volume) and tissuemineral density in Jag1CKO'smaxillary
(green cylinder) bones compared to controls (Figs. 1C, D, E). Additional-
ly, as the bone develops, the orientation of trabecular networks resultsin high anisotropy providing its unique biomechanical properties to
respond differently to forces acting on it from different directions [20].
As such, anisotropy was signiﬁcantly decreased in Jag1CKO maxillary
bones relative to controls (Fig. 1F), suggesting impaired structural deﬁ-
ciencies. Bone volume and bone fraction volume were also diminished
in the palatine bone (red cylinder) of Jag1CKO's when compared to
controls (Figs. 1G, H), however, the median tissue mineral density and
anisotropy in the Jag1CKO palatine bone were no different from those
in the controls (Fig. 1J). The morphological differences observed in the
maxillary and palatine bones of the CKO demonstrate that Jag1CKO
maxillary hypoplasia resulting from the loss of JAG1 signaling in neural
crest cells is associatedwith deﬁcient intrinsic growth and development
of the maxilla hallmarked by reduced mineralization and trabecular
order.
Delayed maxillary ossiﬁcation in Jag1CKO embryos
Histological examination of the maxillary prominence from E14,
E16, and E18 Jag1CKO embryos revealed reduced collagen deposition
using Tri-chrome staining (Fig. 2) and delayed development of mesen-
chymal condensations that becomeossiﬁed boneusingVon Kossa stain-
ing (Fig. 3) when compared to controls. At E14, collagen deposition and
mesenchymal condensations have formed in the anterior lateralmaxilla
(Figs. 2A, B and 3A, B) and the posterior palate shelves of control embry-
os (Figs. 2C, D and 3C, D) whereas Jag1CKO embryos had reduced colla-
gen deposits and mesenchymal condensations compared to controls
(Figs. 2E, F, G, H and 3E, F, G, H). At E16 collagen deposition and
ossiﬁcation of the lateral maxilla expanded medially and continued
within the palatine region posteriorly in control embryos (Figs. 2I, J, K,
L and 3I, J, K, L); whereas, Jag1CKO embryos revealed a poorly organized
pattern of collagen deposition and ossiﬁcation (Figs. 2M, N, O, P and 3M,
N, O, P), whichwas reduced in sizewhen compared to controls. Staining
at E18 revealed the expansion of collagen deposition and ossiﬁed bone
throughout the maxillary and palatine bone within the maxilla in con-
trol embryos (Figs. 2Q, R, S, T and 3Q, R, S, T), and analysis of the same
area within the CKOs demonstrated less collagen deposition and re-
duced overall ossiﬁcation occurring at the same developmental time
point (Figs. 2U, V, W, X and 3U, V, W, X). Quantiﬁcation of the areas of
collagen deposition and ossiﬁcation revealed a signiﬁcant reduction in
the measurements both anteriorly and posteriorly in Jag1CKO embryos
at E14, E16, and E18 when compared to controls (Figs. 2Y and 3Y).
Previous work has shown that theWnt1-cre transgene has resulted in
the expansion of the midbrain with disruption of midbrain dopaminer-
gic neuron differentiation [21]. This phenotype could potentially affect
cranial ossiﬁcation and growth if the size of the midbrain resulted in a
strain on other areas of the skull. Here we compared ossiﬁcation of the
maxilla and the mandible in control and Wnt1-cre+ littermates and
did not ﬁnd any differences in collagen deposition or the formation of
mesenchymal condensations (Sup. Fig. 1).
Reduced expression of osteoblast regulators in Jag1CKO maxillas
Gene expression changes in key regulators of osteoblast develop-
ment and differentiation were analyzed by qPCR on whole maxillary
mRNA from control and Jag1CKO embryos. The mRNA levels of genes
coding for essential regulatory proteins expressed from the pre-
osteoblast stage to the mature osteoblast (Runx2, collagen1, osterix, alk
phos, osteocalcin) were signiﬁcantly reduced at E16 and E18 in Jag1CKO
maxillary tissue relative to controls (Fig. 4A). RUNX2 immunohisto-
chemistry of control and Jag1CKO sections through E14 maxillas
revealed that control embryos developed broad areas of ossiﬁcation
centers (RUNX2+) within the lateral maxillary prominence (Figs. 4B,
C), whereas RUNX2+ areas within Jag1CKO maxillas were drastically
reduced in size (Figs. 4D, E). At E16, the ossiﬁcation centers within
the anterior maxillary prominence have expanded and RUNX2+ cells
are now seen posteriorly within the fused palatine bone of controls
(Figs. 4F, G). However, the expansion of these ossiﬁcation centers
and RUNX2 expression within the palatine bone were reduced in
Fig. 2. Reduced calcium deposition in Jag1CKO maxillas and palates. Tri-chrome staining was performed on anterior and posterior frozen sections through the developing maxilla at
E14 (A–H), E16 (I–P), and E18 (Q–X) in control and Jag1CKO embryos. Reduced areas of calciﬁcation in both the lateral maxillary bone (M) and medial palatine bone (P) was revealed
in Jag1CKO embryos when compared to controls (boxes and graphs). Columns, the mean area obtained from 3 separate experiments; bars, SEM; * = p b 0.05. M= maxilla, PS = palate
shelf, P = palate.
14 C.R. Hill et al. / Bone 62 (2014) 10–21Jag1CKO sections (Figs. 4H, I). Recentwork has identiﬁed a novel role for
JAG1–NOTCH signaling in the establishment of dorsal identity and re-
pression of ventral fates in zebraﬁsh [22]. Evaluation of osteoblast tran-
scriptional regulators, Dlx5/6, Hand2, and End1, active during facial
patterning and dependent on Jagged1 expression, demonstrated alter-
ations in expression with decreases in all of these transcription factors
during later stages of osteoblast development. (Sup. Fig. 2G). These re-
sults reveal that key regulatory proteins required for osteoblast matura-
tion are reduced in Jag1CKO maxillas suggesting that maxillaryossiﬁcation is delayed in Jag1CKO embryos during embryonic develop-
ment of the maxillary prominence, which results in deﬁcient post-
natal bone expansion and growth.
Altered canonical JAG1–NOTCH signaling in the Jag1CKO maxillas
The expression of NOTCH signaling pathway mediators was signiﬁ-
cantly altered by qPCR on whole maxillary mRNA (Fig. 4J). At E14,
Notch1 and Hes1 were signiﬁcantly downregulated in the Jag1CKOs. At
E16, the expression of Notch4, RBPJ, and Hey1 was reduced compared
Fig. 3.Diminished ossiﬁcation in Jag1CKOmaxillary and palatine bones. Von Kossa stainingwas performed on anterior and posterior frozen sections through the developingmaxilla at E14
(A–H), E16 (I–P), and E18 (Q–X) in control and Jag1CKO embryos. Reduced areas of ossiﬁcation in both the lateral maxillary bone (M) and medial palatine bone (P) were revealed in
Jag1CKO embryos when compared to controls (boxes and graphs). Columns, the mean area obtained from 3 separate experiments; bars, SEM; * = p b 0.05. M = maxilla, PS = palate
shelf, P = palate.
15C.R. Hill et al. / Bone 62 (2014) 10–21to controls. At E18, Notch1 andHes1were diminished similar to the E14
analysis. These data indicate that aberrant signaling within the
JAG1–NOTCH canonical pathway in the Jag1CKO occurs during the
critical time points of maxillary ossiﬁcation.
Reduced in vitro differentiation and ossiﬁcation in Jag1CKO
MEMM cells
Mouse embryonic maxillary mesenchymal (MEMM) cells were
harvested from control and Jag1CKO embryos at E14 and cultured inosteogenic media (OM) + BMP2 to induce differentiation and mineral-
ization.Mineralizationwasdecreased in Jag1CKOMEMMcells following
a 16 d differentiationwhen compared to controls (Figs. 5A–E). Similarly,
the induction of osteoblast regulatory genes was signiﬁcantly down-
regulated in Jag1CKO cells compared to controls following differentia-
tion (Fig. 5F). However, cell proliferation was signiﬁcantly increased in
Jag1CKO MEMM cells compared to controls after the 16 d incubation
in OM (Fig. 5G). These data indicated that Jag1CKO MEMM cells had
an intrinsic deﬁciency in their ability to respond to BMP2-induced
Fig. 4. Aberrant osteoblast development and differentiation in Jag1CKO maxillas. qPCR revealed a decrease in the induction of osteoblast differentiation genes at both E16 and E18 in
Jag1CKOwholemaxillarymRNAwhen compared to control littermates at the same developmental time point (A). Columns, themedian fold change obtained from3 separate experiments;
bars, SEM; * = p b 0.05. Immunohistochemistry (B–I): Frozen sections from the anterior and posterior developing maxilla in control and Jag1CKO were stained with an early marker
of osteoblast differentiation, RUNX2, and endothelial cell marker, PECAM. The density of RUNX2 staining (boxes) was reduced in Jag1CKO maxillas at E14 (D, E) and E16 (H, I) when
compared to control littermates (B, C, F, G). n = 3 for each time point. M = maxilla, PS = palate shelf, P = palate. qPCR was used to compare the expression of Jagged1 ligand, Notch
1 and 4 receptors, and downstream effectors: RBPJ, Hes1, and Hey1 in Jag1CKO whole maxillary mRNA at E14, E16, and E18 to control littermate whole maxillary mRNA at the same
developmental time point (J). Columns, the mean fold change obtained from 3 separate experiments; bars, SEM; * = p b 0.05.
16 C.R. Hill et al. / Bone 62 (2014) 10–21osteoblast differentiation and form ossiﬁed bone. Increased prolifera-
tion in the Jag1CKO cells suggested that the mesenchymal precursors
were stuck in the proliferative phase that occurs prior to osteoblast
commitment during ossiﬁcation.
Inhibition of JAG1–NOTCH signaling results in reduced mineralization
in vitro
The presence of γ-secretase inhibitor DAPT (50 μM) during the
entire 16 d differentiation period reduced alizarin red staining in control
MEMM cells (Sup. Figs. 3A–D). Quantiﬁcation of the stained cellsrevealed an approximately 2 fold decrease in the incorporation of aliza-
rin red in cells treatedwithDAPT (Sup. Fig. 3E). These results are consis-
tent with the necessity of the JAG1–NOTCH signaling axis during
MEMMmineralization.
Altered BMP ligand and receptor expression in Jag1CKO MEMM cells
in vitro
The reduced ability of the Jag1CKOMEMM cells to respond to BMP2
induction of osteoblast differentiation in vitro suggested that the BMP
pathway was altered by the loss of JAG1 in CNC cells. qPCR analysis of
Fig. 5.Reducedmineralization and osteoblast differentiation in Jag1CKOMEMMcells in vitro. Control and Jag1CKOMEMMcellswere incubated in growthmedia (GM) or osteogenicmedia
(OM) for 16 days and stained with alizarin red to analyze mineralization (A–D). The alizarin red stain was solubilized and quantiﬁed (E). qPCR revealed the induction of osteoblast
differentiation markers in mRNA extracted from the cells (F). Differentiated Jag1CKO cells (OM-CKO) were compared to Jag1CKO cells incubated in GM. Differentiated control cells
(OM-control) were compared to control cells in GM. Columns, the mean fold change obtained from 3 separate experiments; bars, SEM; * = p b 0.05 compared to GM; $ = p b 0.05
compared to OM-control. Cell proliferation following 16 d differentiation in OMwas measured by BrdU ELISA and total DNA extraction (G). Columns, the mean obtained from 3 separate
experiments; bars, SEM; * = p b 0.05.
17C.R. Hill et al. / Bone 62 (2014) 10–21undifferentiated MEMM cells revealed a 23 fold increase in the expres-
sion of BMP2, 1.5 fold increase in ALK2 (BMPR1b), 1.7 fold increase in
ALK3 (BPMR1a), and 1.5 fold increase in BMPR2 in Jag1CKO MEMM
cells compared to controls (Fig. 6A). There was no signiﬁcant difference
in the expression of BMP4 (Fig. 6A). Following 16 d differentiation in
OM+ BMP2 a 6 fold increase in the expression of BMP2was revealed
while BMP4, ALK3 (BMPR1a), and BMPR2were all signiﬁcantly reduced
by 2 fold, 1.7 fold, and 1.8 fold, respectively, in the Jag1CKOMEMM cells
(Fig. 6B). No signiﬁcant difference was seen in the expression of ALK2
(BMPR1b) following differentiation (Fig. 6B). These data suggest that
Jag1CKO MEMM cells cannot appropriately respond to the signals
that induce osteoblast differentiation due to the misexpression of BMP
pathway molecules at both the mesenchymal cell stage as well as
post-differentiation.
BMP signaling molecules are dysregulated in Jag1CKO maxillas
qPCR on whole maxillary mRNA from control and Jag1CKO embryos
revealed gene expression differences in BMP pathway molecules at E14
and E16 (Fig. 6C), but no differences at E18 (data not shown). At E14,analyses detected small, however signiﬁcant, increases in the expres-
sion of BMP2 (1.2 fold), BMP4 (1.6 fold), ALK2 (BMPR1b) (1.3 fold),
and ALK3 (BMPR1a) (1.2 fold), but no difference in BMPR2 (Fig. 6C).
Similarly, the expression of BMP2, ALK2 (BMPR1b), ALK3 (BMPR1a),
and BMPR2 was increased by 1.1, 1.3, 1.1, and 1.2 fold, respectively, at
E16, however no difference was revealed in BMP4 (Fig. 6C). These data
are consistent with what was shown in undifferentiated Jag1CKO
MEMM cells suggesting that themesenchymal cells within the Jag1CKO
maxillas have alterations in the genes regulating osteoblast differentia-
tion leading to an intrinsic delay in osteoblast development.JAG1-Fc rescues in vitro MEMM cell ossiﬁcation
The presence of immobilized JAG1-Fc enhanced the mineralization
of Jag1CKOMEMM cells cultured in OM with BMP2 (Figs. 7A–D). Addi-
tionally, qPCR analysis revealed that Jag1-Fcwas sufﬁcient for the induc-
tion of genes regulating osteoblast differentiation (Runx2, collagen1,
alkaline phosphatase, and osteocalcin) (Fig. 7E) during in vitro ossiﬁca-
tion assays. Taken together, these data demonstrated that JAG1-Fc was
Fig. 6.Misexpression of BMP ligands and receptors in Jag1CKO MEMM cells in vitro and in vivo. Control and Jag1CKO MEMM cells were incubated in either growth media (GM) or oste-
ogenicmedia (OM) for 16 days, andqPCRwasused compare the expression of BMP ligands and receptors. A:mRNA levels in undifferentiated Jag1CKO cells (OM-CKO) relative to the levels
in undifferentiated control cells (OM-control). B:mRNA levels in differentiated Jag1CKO cells (OM-CKO) relative to the levels in differentiated control cells (OM-control). C: Jag1CKOwhole
maxillary mRNA at E14 and E16 relative to control littermate whole maxillary mRNA at the same developmental time point (J). Columns, the mean fold change obtained from 3 separate
experiments; bars, SEM; * = p b 0.05.
18 C.R. Hill et al. / Bone 62 (2014) 10–21necessary to rescue the deﬁciency in osteoblast development and differ-
entiation in response to OM+ BMP2 in Jag1CKO MEMM cells.Discussion
Conditional targeted deletion of Jag1 in CNC cells demonstrated
several important cell-autonomous roles of JAG1 during maxillary ossi-
ﬁcation. We demonstrated the necessity of Jagged1 in the maxillary
mesenchyme in vivo and inMEMMcells in vitro during osteoblast differ-
entiation (Sup. Figs. 2A–F), supporting the importance of Jagged1
mesenchymal cell-autonomous signaling. Maxillary hypoplasia due to
the loss of Jagged1was characterized by aberrant osteoblast regulatory
gene expression, associatedwith histologic, and μCTﬁndings of aberrant
bone formation. Abrogation of JAG1–NOTCH signaling in maxillary
mesenchymal cells resulted in an overall delay in osteoblast develop-
ment and differentiation, which may be due in part to altered BMP sig-
naling, and was rescued by exogenous JAG1. This study demonstratedthe requirement of Jagged1 during osteoblast maturation and ossiﬁca-
tion, which were critical for normal maxillary development.
Maxillary hypoplasia associated with aberrant osteoblast
development in Jag1CKO mice
CNC cellsmigrate from the dorsal neural tube and populate themax-
illary prominence with mesenchymal osteoblast precursors [23,24].
The maxillary bone is formed through intramembranous ossiﬁcation
where the mesenchymal condensations differentiate directly into pre-
osteoblast and form ossiﬁcation centers with no cartilaginous phase
[1]. Themaxillary bone comprises the fusion of the lateralmaxillary pro-
cesses and the palatine bones, both of which are derived after fusion of
the palate shelves. Osteoblast differentiation begins in the lateral maxil-
la and continues medially while ossiﬁcation of palatine bone begins
as an independent process. Expansion of these ossiﬁcation centers
continues until ossiﬁcation of the maxillary prominence is complete.
Conditional deletion of Jagged1 in the CNC led to maxillary hypoplasia
that phenocopied the facial features of Alagille syndrome patients who
Fig. 7. JAG1-Fc is sufﬁcient to rescue mineralization and osteoblast marker induction. Jag1CKO MEMM cells were incubated in growth media (GM), osteogenic media in the presence
of immobilized IgG (OM + IgG), or osteogenic media in the presence of immobilized Jagged1-Fc (OM + Jag1-Fc) for 16 days and stained with alizarin red to analyze mineralization
(A–C). The alizarin red stain was solubilized and quantiﬁed (E). qPCR revealed the induction of osteoblast differentiation markers in mRNA extracted from the cells. Columns, the mean
fold change obtained from 3 separate experiments; bars, SEM; * = p b 0.05 compared to GM; $ = p b 0.05 compared to OM+ IgG.
19C.R. Hill et al. / Bone 62 (2014) 10–21have JAG1 or NOTCH mutations [4]. Jag1CKO mice had reduced bone
density that was poorly organized post-natally (Fig. 1). Our data sug-
gests that the post-natal phenotype was a result of reduced collagen
deposition (Fig. 2) and delayed ossiﬁcation (Fig. 3) associated with
reduced osteoblast regulatory gene expression required for normal
osteoblast development and differentiation (Fig. 4). Similarly, Bmpr1a,
or ALK3, conditional mutant mice have delayed palatal bone formation
and reduced osteoblast regulatory gene expression; however, these
mice die shortly after birth due to cleft palate formation preventing
post-natal evaluation of bone development [25]. Palatal bone defects
result from osteoblasts failing to mature which occur in Tbx22 null
mice as shown by a complete lack of mineralized bone, and these
mice also die at birth due to cleft palate formation and choanal atresia
[26]. The Jag1CKO model of intrinsic maxillary hypoplasia uniquely
allows the examination of maxillary osteoblast development and differ-
entiation as well as early post-natal maxillary growth.
JAG1 signaling is required for maxillary osteoblast development and
differentiation
JAG1–NOTCH signaling was required during osteoblast maturation,
but there are conﬂicting reports as to whether the NOTCH pathway
plays an inductive or inhibitory role during ossiﬁcation. Over-expression
of the NOTCH intracellular domain (NICD) in pre-osteoblast mesenchy-
mal cells repressed differentiation and led to osteopenia [27]. However,
NICD over-expression in later stage committed osteoblasts resulted in
abnormal proliferation and osteosclerosis [28]. HEY1, a direct down-
stream target of JAG1–NOTCH signaling, has been shown to suppress
RUNX2, the earliest pre-osteoblast regulator of differentiation [29].
Conversely, inhibition of NOTCH signaling in MC3T3 cells was shown to
result in decreased regulators of bone development: Runx2, alkaline
phosphatase, collagen1, and osteocalcin [7]. Several recent studies demon-
strated that JAG1 acts to induce mesenchymal stem cells to differentiate
into osteoblasts and undergomineralization [5,30]. In these studies, JAG1induced the expression of bone sialoprotein and alkaline phosphatase,
demonstrating the role of JAGGED1 during the induction of mesenchy-
mal cells into osteoblasts [30]. In addition, mutations in Jag1 cause
Alagille syndrome in humans which is associated with craniofacial
defects, butterﬂy vertebrae, digit abnormalities, osteoporosis, and pedi-
atric bone fractures, suggesting that JAG1 plays an important role in
human bone development and maintenance [31]. In Jag1CKO maxillary
mesenchymal cells, JAG1was required both in vivo and in vitro for the in-
duction of osteoblast regulatory genes, such as Runx2, collagen1, alkaline
phosphatase, osterix, and osteocalcin (Figs. 4 and 5). Additionally, replace-
ment of JAG1 in vitro was sufﬁcient to rescue gene expression (Fig. 7)
demonstrating the sufﬁciency of JAG1 to induce osteoblast dif-
ferentiation in response to OM. Analysis of JAG1–NOTCH canonical path-
way members in Fig. 4J revealed decreased Notch 1, Notch 4, Hes1 and
Hey 1 expression during critical time points of maxillary ossiﬁcation.
Taken together, these data suggests that JAG1, likely acting through the
canonical NOTCH pathway, was required for the induction of osteoblast
development and differentiation in maxillary mesenchyme during
intramembranous ossiﬁcation. Previously published data from our lab
revealed decreased proliferation within the maxillary mesenchyme at
E14, but not at P14 [4],which suggested that lack of proliferation contrib-
uted to the phenotype seen in the Jag1CKO. Here we show that MEMM
cells have increased proliferation, but decreased mineralization, at the
end of a 16 d differentiation in OM+BMP2 (Fig. 5G). These data suggest
that the Jag1CKO mesenchymal progenitors, unable to undergo osteo-
blast differentiation, continue to proliferate, where the control cells
have already passed the proliferative phase and are ossifying.
JAG1–NOTCH signaling during patterning of the vertebrate facial
skeleton
Facial skeletal development occurs through the complex patterning
of CNC cells along the dorsoventral axis. Elegant studies of Jagged1's
role during dorsal and ventral craniofacial development in zebraﬁsh
Fig. 8. Jagged1 cell autonomous signaling is required in CNC-derived maxillary mesenchyme during osteoblast development and differentiation.
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Hand2, all of which are transcription factors necessary for osteoblast
differentiation [22]. In the zebraﬁsh model BMP2 plays a prominent
role of inducing Hand2 expression, which represses Dlx5/6 expression.
In the Jag1CKO mice, the expression of Dlx5, Dlx6, Hand2, and End1 is
dysregulated at each developmental time point analyzed (Sup. Fig. 2G).
These data suggested that, similar to zebraﬁsh, Jagged1 signaling affects
the expression of these ventral specifying transcription factors, thus
affecting patterning of the maxilla, a dorsal structure. Furthermore, the
alteration in Dlx5, Dlx6, Hand2, and End1 expression during maxillary
osteoblast differentiation suggests that these transcription factors are
down-stream of Jagged1 functioning, and that their dysregulated expres-
sion was associated with reduced maxillary osteoblast differentiation.
Altered BMP signaling in Jag1CKO MEMM cells
The role of BMP signaling in facial skeletal development has been
extensively studied; with a recent report demonstrating the necessity
of BMPR1a (ALK3) during palate ossiﬁcation [25]. The absence of
BMPR1a (ALK3) led to reduced growth of the palate shelves, deﬁcient
bone formation of themaxillary and palatine bones, and cleft palate for-
mation associated with reduced proliferation within the mesenchyme
and misexpression ofMsx1, Fgf10, and Shh [25]. Interestingly BMPR1a,
or ALK3, as well as BMPR2 and BMP4 expression was signiﬁcantly re-
duced in Jag1CKO MEMM cells following 16 d differentiation in vitro
(Fig. 6). BMP2 has been shown to induce the expression of canonical
NOTCH target HEY1 [29]. Inhibition of NOTCH1, the canonical JAG1
receptor, has been shown to reduce BMP target genes, such as Id1, sug-
gesting that theNOTCH and BMPpathwaysmay function synergistically
[7]. In addition, JAG1–NOTCH signaling was essential for BMP2 induced
osteoblast differentiation and BMP signaling itself in humanmesenchy-
mal stem cells [7]. Jag1CKO MEMM cells had reduced mineralization
in vitro in response to BMP2 (Fig. 5) that was associated with reduced
expression of osteoblast regulatory genes (Fig. 5) suggesting that
Jag1CKO cells were unable to respond to BMP2 induced osteoblast
differentiation. However, the expression of BMP2 as well as the BMP re-
ceptors ALK2, ALK3, and BMPR2 was signiﬁcantly greater in Jag1CKO
MEMM cells in vitro than in controls prior to osteoblast differentiation
(Fig. 6). Additionally, in vivo expression of the same BMP signalingmol-
ecules was signiﬁcantly greater in Jag1CKOwholemaxillarymRNA than
in controls at E16 which is a critical point of maxillary ossiﬁcation. This
suggested that Jag1CKOmesenchymal cells have up-regulated BMP sig-
naling, possibly to compensate for their inability to respond to osteo-
inductive signals during maxillary mesenchymal differentiation. This
failure to respond to osteo-inductive signals results in an overall inabil-
ity in their genetic program to regulate osteoblast development and dif-
ferentiation. Followingdifferentiation in vitro, BMP2 expressionwas still
increased, but the BMP receptors were decreased indicating that the
timing of induction of BMP pathway molecules was misregulated.Future studies will determine the mechanism by which JAG1 regulates
the reception of BMP and whether maxillary hypoplasia in Jag1CKO
mice is due to the loss of responsiveness to BMP signaling (Fig. 8).
Conclusion
Taken together, these data demonstrated that JAG1 cell-autonomous
signaling in CNC cells was required for normal maxillary osteoblast
development and differentiation (Fig. 8), and the loss of JAG1 led to
post-natal intrinsicmaxillary hypoplasia characterized by delayedmax-
illary ossiﬁcation and aberrant bone formation. Uncovering the impor-
tance of JAG1 signaling to BMP-responsiveness of the CNC derived
mesenchyme during osteoblast differentiation and ossiﬁcation is an
important ﬁrst step towards understanding the pathways necessary
for maxillary formation. Understanding themechanisms of JAG1 signal-
ing during maxillary development may increase our understanding of
intrinsic maxillary hypoplasia in humans.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bone.2014.01.019.
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